OTC Drugs, Medical Devices and Diagnostics 2020-2024 with Profiles of Leading Market Players Including 3M, Akron, Bayer AG, Celgene and Eli Lilly and Co.

News provided by

Oct 01, 2020, 18:15 ET

DUBLIN, Oct. 1, 2020 /PRNewswire/ -- The "OTC Drugs, Medical Devices and Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.

The report covers developed and emerging markets in order to help readers understand:

Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
The current state of the market and the key markets for its future development.
Major regional trends.
Market drivers and restraints.
Detailed market projections through 2024.
Global competitive thrust in terms of competition and market shares.
Key marketed and pipeline (research and development) products along with information about their regulatory status.
Strategic landscape (mergers and acquisitions).
Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
Pricing and reimbursement.
Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
Profiles of market participants and associations.

The Report Includes:

26 data tables and 22 additional tables
An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
Analyses of global market trends with data from 2018 and 2019, and projections of CAGRs through 2024
Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.

Companies Mentioned

3M
Abbott Laboratories
Abbvie Inc.
Acadia Pharmaceutical
Acorda Therapeutics
Actavis plc
Actualmeds
Aethlon Medical Inc.
Agenus
Akron
Alacer Corp.
Alcon Inc.
Alere Inc.
Alfresa Pharma Corp.
Aliphcom Inc.
Alivecor
Alkalon A/S
Alkermes
Allergan
Alliance Healthcare
Amgen Inc.
Amiko
Amneal Pharmaceuticals
Anavex Life Sciences
Ani Pharmaceuticals
Apotex
Archos
Arena Pharmaceuticals
Array Biopharma
Asahi Kasai Corp.
Aslan Pharmaceuticals
Aspen Pharmacare
Astellas Pharma Inc.
Astrazaneca plc
Athersys
Audentes Therapeutics
Axiobionics
Axsome Therapeutics
Bausch & Lomb
Bausch Health
Baxter International Inc.
Bayer AG
Beigene
Bespak Europe
Biomerieux
Biosensics
Bioserenity
Biotricity
Biotronik
Biovotion
Bioxcel Therapeutics
Bodytel
Boehringer Ingelheim
Boston Scientific
Brainmarc
Bristol-Myers Squibb
BTS Bioengineering
Carma Laboratories, Inc.
Celgene
Chattem Inc.
Chugai Pharmaceuticals Co. Ltd.
Cilag AG
Cipla
Cleveland Medical Devices
Colgate-Palmolive Co.
Connectedhealth Pte. Ltd.
Consort Medical
Corbus Pharmaceuticals
Cspc Pharmaceutical Group
Daiichi Sankyo
Derma Sciences
Dexcom Inc.
Dr. Reddy'S Laboratories Ltd.
Earlysense
Eisai
Eli Lilly and Co.
Empatica
Endo International
Endoceutics Inc.
Endotronix
Entra Health Systems
Erytech Pharma
Esteve
Everist Health
Eyescience Labs
Fertin Pharma A/S
Gaba Schweiz
Galderma S.A.
Gemini Pharmaceuticals Inc.
Genomma Lab International
Gilead Sciences
GlaxoSmithKline plc
Glooko Inc.
Glucovista Inc.
Health Care Originals
Hikma Pharmaceuticals
Hisamitsu Pharmaceutical Co. Inc.
Hocoma
Ihealth Lab Inc.
Immunomedics
Impact Sports Technologies
Impak Health
Infobionic Inc.
Insulet Corp.
Intelesens
Intra-Cellular Therapies
Iovance Biotherapeutics
Ipsen S.A.
Jan Medical Inc.
Jiangsu Hengrui Medicine
Johnson & Johnson
Kowa Co. Ltd.
Kyowa Hakko Kirin
Lake Consumer Products Inc.
Les Laboratoires Servier
Livanova plc
Lundbeck
Lupin
Mallinckrodt plc
Manx Healthcare Ltd.
Meda Ab
Medminder
Medtronic
Melaleuca Inc.
Menarini
Merck
Merz Pharma
Mio Global
Mitsubishi Tanabe Pharma
Mochida Pharmaceutical Co. Ltd.
Mycardio LLC
Mylan Inc.
Nemaura Medical Inc.
Neofect Co. Ltd.
Neurocrine Biosciences
Neurometrix Inc.
Neurovigil Inc.
Neutrogena Corp.
Novartis
Novasom Inc.
Novo Nordisk
Now Foods
Nucana
Omada Health Inc.
Omnicell Inc.
Omron Corp.
Ono Pharmaceutical Co. Ltd.
Orion Pharma Ltd.
Orpyx Medical Technologies
Otsuka Pharmaceuticals
Pacira Pharmaceuticals Inc.
Perrigo plc
Pfizer
Pharmavite LLC
Philosys
Pierre Fabre Pharmaceuticals Inc.
Piramal Healthcare Ltd.
Polar Electro Oy
Prestige Brands Holdings Inc.
Preventice Inc.
Prizm Medical Inc.
Propeller Health
Proteostasis Therapeutics
Proteus Digital Health Inc.
Qardio
Reckitt Benckiser plc.
Recordati Pharma GmbH
Revolymer (U.K.) Ltd
Rexahn Pharmaceuticals
Roche
Sage Therapeutics
Sanofi
Sarepta Therapeutics
Sato Pharmaceutical Co. Ltd.
Sense4Care
Senseonics Holdings
Senticare Inc.
Shaklee Corp.
Shanghai Pharmaceuticals Holding
Shionogi and Co. Ltd.
Silvergens
Sproutling Inc. (Acquired by Mattel)
Stada Arzneimittel AG
Sumitomo Dainippon Pharma Co. Ltd.
Sun Pharmaceutical Industries
Swisse Wellness Pty Ltd.
Taisho Pharmaceutical
Takeda Pharmaceutical Co. Ltd.
TCR2 Therapeutics
Teva Pharmaceutical Industries
Tisso Naturprodukte GmbH
Towerview Health Inc.
Translate Bio
Tyme Technologies
UCB
Unilife Corp.
Vaica
Vertex Pharmaceutical
Vital Connect
Wellspring Pharmaceutical Corp.
West Pharmaceutical Services Inc.
Winmedical Srl
Ybrain
Ypsomed Holding AG
Zeavision LLC
Zogenix Inc.
Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/r/x55pk7

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets